Radioassay kit for method of determining methotrexate

Special receptacle or package – Combined or convertible – Packaged assemblage or kit

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

23253R, 424 1, A61B 1900, A61K 4300

Patent

active

041024559

ABSTRACT:
A radioassay system for the determination of methotrexate in biological fluids based on the competitive binding of labeled and unlabeled methotrexate to the enzyme dihydrofolate reductase. Samples of unknown methotrexate level are mixed with I.sup.125 labeled methotrexate. A portion of the total methotrexate present is bound by the addition of enzyme, and the unbound methotrexate is removed with charcoal. The level of bound I.sup.125 labeled methotrexate is measured in a gamma counter. To calculate the methotrexate level of the unknown samples, the displacement of bound labeled methotrexate caused by the unknowns is compared to the displacement caused by known methotrexate standards.

REFERENCES:
patent: 3981983 (1976-09-01), Caston et al.
patent: 3989812 (1976-11-01), Barrett et al.
patent: 4043759 (1977-08-01), Charm et al.
Croll et al., Ed., New Techniques in Tumor Location and Radio Immuno Assay, John Wiley & Sons, N.Y., 1974.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Radioassay kit for method of determining methotrexate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Radioassay kit for method of determining methotrexate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioassay kit for method of determining methotrexate will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1417207

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.